Relationship between cognitive performance and mobility in Parkinson’s disease
Objective: Investigate relationship between cognitive performance and mobility in persons with Parkinson’s disease (PD). Background: Persons with PD experience both motor and non-motor symptoms. Two…MCI reverters have a favorable cognitive prognosis and cortical integrity in Parkinson’s disease
Objective: To investigate whether reversion to cognitively normal status (CogN) is clinically relevant in Parkinson’s disease with mild cognitive impairment (PD-MCI). Background: The concept of…The Association between Cognition and Balance in idiopathic Parkinson’s Disease
Objective: To investigate whether balance function is associated with cognitive function in patients with idiopathic Parkinson’s disease (iPD) and to compare the association between freezers…Negative and Positive Feedback Processing in Parkinson’s Disease and Impulse Control Disorder: an ERP Study
Objective: To investigate neural correlates of positive and negative feedback processing during reward-related decision-making using the Balloon Analogue Risk task (BART) and event-related potentials (ERPs).…Cognitive complaint in Parkinson’s disease patients with normal cognition: Canary in the coal mine?
Objective: To determine the frequency and impact of cognitive complaints in Parkinson’s disease (PD) patients with normal cognition (NC). Background: PD patients are at a…Vascular white matter involvement in Idiopathic Normal Pressure Hydrocephalus: association with cognitive and motor impairment
Objective: To explore the relationship between vascular subcortical encephalopathy, ventricular dilation and clinical severity in idiopathic normal pressure hydrocephalus (iNPH). Background: The frequent co-occurrence of…The contribution of striatal dopamine to feedforward motor control during gait initiation in Parkinson’s disease
Objective: To establish the contribution of striatal dopamine to gait initiation in Parkinson’s disease. Background: Gait initiation (GI) is characterized by anticipatory postural adjustments (APAs),…Skin could be the new peripheral tissue of interest in Parkinson’s disease transcriptomics
Objective: Profiling gene expression changes in peripheral tissues in PD. Background: Obtaining tissue for gene expression analysis in PD from CNS is done post mortem.…Experimental model of developing of Parkinson’s disease
Objective: Analyzing the reserpine model of Parkinsonian syndrome Background: There are several experimental models of Parkinson's disease: reserpine, methamphetamine, 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine - substances that…Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson’s disease
Objective: Verification of the previously reported association between chronic use of β2-adrenoreceptor (β2AR) agonist and antagonist with reduced and increased risk of Parkinson’s disease (PD),…
- « Previous Page
- 1
- …
- 117
- 118
- 119
- 120
- 121
- …
- 217
- Next Page »